The grant from NINDS funds a gene expression analysis core for an existing project on type 1 regulatory T-cell development. 

A new study examined the impact of whole-genome sequencing on the detection of BRCA and other cancer susceptibility mutations.

Caprion will use its discovery and targeted mass spec platforms to analyze roughly 400 samples from the UK Collaborative Trial for Ovarian Cancer Screening.

Jennifer Kulynych and Hank Greely argue at Slate that as genomic information is folded into medical records, research practices will have to change. 

The US Centers for Disease Control and Prevention is searching for a safety chief following several mishaps.

HTG plans to list its shares on the Nasdaq and is the 11^th firm this year in the MDx/omics tools space to either go public or file for an IPO.

Unlike some current methods, the new tool does not rely on pre-specified mutation rates, and successfully avoids some of the limitations associated with that approach.

In Genome Biology this week: regional mutational patterns differences within tumors, genetic signature shared among endangered bird species, and more.

Genetic screens may pick up more than patients bargain for, and researchers and policymakers are working out how to deal with such incidental findings.

Tute Genomics has tapped Andrew Olson to serve as its vice president of sales. Prior to joining the company, Olson was VP of sales at Great Basin Corporation, a Utah-based healthcare technology firm. He's also worked as VP of sales and marketing at Signature Genomics.

By combining interactome, candidate gene data, and more, Stanford researchers tie a network of proteins expressed in the corpus callosum to autism.

The work focuses on using microRNA signatures in breath condensate to assess an individual's risk of developing lung cancer.

Exact replication of studies may not be the answer to the question of reproducibility in science, Pacific Standard says.

The Australian company will use proceeds to ramp up the commercialization of its breast cancer test.

An analysis in the Proceedings of the National Academy of Sciences suggests the association between obesity and an FTO gene variant became increasingly significant in the past several decades.

In PNAS this week: factors modulating association between BMI and FTO gene variants, circadian cycle gene expression changes, and more.

Pressures, including reimbursements and flat NIH funding, continued to dampen M&A in the past year, but one expert said that the picture may be brighter than it appears.

The companies will offer an evidence-based genetics benefits program to ensure the appropriate use of such tests and deliver cost savings.

The grants will fund projects to create new technologies, validate and refine existing ones, and add single-cell components to existing projects. 

The firm will use the proceeds for sales and marketing, R&D, debt repayment, and other purposes. 

GenomeWeb asked Gutierrez questions we have been hearing from industry players on its plan to regulate LDTs and a few other issues impacting the personalized medicine field.

Newborn sequencing studies are expected to begin in the coming year.

The Atlantic examines whether historically black colleges and universities bolster minority representation in the sciences.

Richard Schumacher was reelected as a director of Pressure BioSciences. He will serve as a Class III director until the company's 2017 annual shareholders' meeting. Schumacher is the founder of Pressure Bio and is its president and CEO.

Cary Anne Simpson has been named the new director of North American sales for VUV Analytics, a gas chromatography instrument manufacturer based in Austin, Texas. Simpson joins the firm from Thermo Fisher Scientific where she was most recently the national sales manager for the clinical controls product line. She also served Thermo Scientific as a North American sales manager of the Discrete Analyzer business as well as a regional sales manager in the Chromatography and Mass Spectrometry Division. Simpson also has worked in sales and sales management for Dionex and Polymer Laboratories.